Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Graph AI is in talks to raise $14 Mn in a Series A funding round led by Insight Partners, with participation from Bessemer Venture Partners, to support its AI-native platform for drug monitoring.
PRIVATEJul 06, 2026•15 days ago
Amount Raised
$14 Million
Round Type
Series A
PleasantonInformation Technology
Investors
Bessemer Venture PartnersInsight Partners
Description
Graph AI is in discussions to raise $14 Mn in a Series A funding round. The round will be led by Insight Partners and also includes existing investor Bessemer Venture Partners. This funding aims to support the company's AI-native platform, Graph Safety, in enhancing pharmaceutical safety monitoring. The discussions are ongoing, and the funding amount may change.
Company Information
Company
Graph AI
Location
Pleasanton, California, United States
About
Graph AI is focused on enhancing patient safety and pharmacovigilance through an AI-native safety platform. The company aims to transition pharmaceutical companies from manual, error-prone workflows to highly automated systems that improve efficiency and regulatory compliance. Founded in 2024, Graph is led by industry veterans with extensive experience in global organizations. They have quickly built a significant customer pipeline and reported impressive efficiency gains.